PDE10A and cancer: We then restricted the analysis to only patient-matched FLC and NML samples in an independent cohort from the Fred Hutchinson Cancer Center (Fig 1C, n = 5), as well as in a subset of Cohort 1 (Fig 1D, n = 9; S1B Fig) and confirmed that LINC00473 is indeed significantly elevated in FLC (fold-change > 50).